A novel targeted therapy in breast cancer: cyclin dependent kinase inhibitors.
about
Current medical treatment of estrogen receptor-positive breast cancerNew targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancersCyclin-dependent kinase 11(p110) (CDK11(p110)) is crucial for human breast cancer cell proliferation and growthGenomics of gallbladder cancer: the case for biomarker-driven clinical trial design.Targeted therapies in breast cancer: New challenges to fight against resistance.UHRF1 promotes breast cancer progression by suppressing KLF17 expression by hypermethylating its promoter
P2860
A novel targeted therapy in breast cancer: cyclin dependent kinase inhibitors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A novel targeted therapy in breast cancer: cyclin dependent kinase inhibitors.
@en
type
label
A novel targeted therapy in breast cancer: cyclin dependent kinase inhibitors.
@en
prefLabel
A novel targeted therapy in breast cancer: cyclin dependent kinase inhibitors.
@en
P2093
P1476
A novel targeted therapy in breast cancer: cyclin dependent kinase inhibitors.
@en
P2093
Furkan Sarici
Kadri Altundag
Serkan Akin
Taner Babacan
P577
2014-01-01T00:00:00Z